These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 19256346)
1. [Expression and function identification of extracellular domain 3 of human vascular endothelial growth factor receptor KDR]. Zhang J; Zhang Y; Li H; Chen W; Zhang T; Wang M Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1962-7. PubMed ID: 19256346 [TBL] [Abstract][Full Text] [Related]
2. Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors. Zhang J; Li H; Chen W; Cao P; Wang M Biotechnol Prog; 2009; 25(6):1703-8. PubMed ID: 19731341 [TBL] [Abstract][Full Text] [Related]
3. Production of neutralizing monoclonal antibody against human vascular endothelial growth factor receptor II. Li R; Xiong DS; Shao XF; Liu J; Xu YF; Xu YS; Liu HZ; Zhu ZP; Yang CZ Acta Pharmacol Sin; 2004 Oct; 25(10):1292-8. PubMed ID: 15456530 [TBL] [Abstract][Full Text] [Related]
4. [Effect of monoclonal antibody against extracellular domain III of vascular endothelial growth factor receptor KDR on proliferation of vascular endothelial cells]. Li R; Xiong DS; Shao XF; Xu YF; Zhu ZP; Yang CZ Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):209-12. PubMed ID: 15949417 [TBL] [Abstract][Full Text] [Related]
5. [Cloning, expression and purification of KDR tyrosine kinase]. Liu C; Zhang Y; Li Y Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1545-9. PubMed ID: 19160835 [TBL] [Abstract][Full Text] [Related]
6. [Soluble-expression, purification and activity analysis of extracellular domain III of flt1]. Xie Y; Gu Y; Huang R; Li X; Du X; Wang J; Xiong D; Yang C; Xu Y Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):580-6. PubMed ID: 19637635 [TBL] [Abstract][Full Text] [Related]
7. [Prokaryotic expression and characterization of an anti-KDR single chain antibody]. Li R; Xiong DS; Xu YF; Shao XF; Fan DM; Zhu ZP; Yang CZ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):39-42. PubMed ID: 15629080 [TBL] [Abstract][Full Text] [Related]
8. [Prokaryotic expression, purification and identification of VEGFR2 D3.4/GST fusion protein in E.coli]. Wei YY; Song CJ; Sun YJ; Gong JY; Jin BQ; Yang AG; Yang K Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):870-2. PubMed ID: 18782519 [TBL] [Abstract][Full Text] [Related]
9. A fusion fragment from Flt-1 and KDR, acted as VEGF decoy receptor and exhibited anti-tumor function. Li ZL; Yao XJ; Liu WF; Chen GJ Biotechnol Lett; 2010 Nov; 32(11):1609-13. PubMed ID: 20607359 [TBL] [Abstract][Full Text] [Related]
10. Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase. Zhao G; Peery RB; Yingling JM Anal Biochem; 2007 Jan; 360(2):196-206. PubMed ID: 17141171 [TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2. Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200 [TBL] [Abstract][Full Text] [Related]
12. [Cloning, expression of soluble VEGFR2 fragment and its effect on tumor angiogenesis]. Kou BJ; Li YL; Zhang LH; Zhu GB; Wang XR; Li YL; Wang YZ; Shi YA Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):337-41. PubMed ID: 15312342 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a functionally active collagen-binding vascular endothelial growth factor fusion protein in situ. Ishikawa T; Eguchi M; Wada M; Iwami Y; Tono K; Iwaguro H; Masuda H; Tamaki T; Asahara T Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1998-2004. PubMed ID: 16794220 [TBL] [Abstract][Full Text] [Related]
14. [Cloning and prokaryotic expression of Bifidobacterium infantis-mediated sKDR and its effect on proliferation of vascular endothelial cells]. Mao SH; Ji LL; Liu H; Xu YZ; Huang H; Huang Y; Yi C Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):784-6, 802. PubMed ID: 19950583 [TBL] [Abstract][Full Text] [Related]
16. The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain. Li H; Cao W; Chen Z; Acheampong DO; Jin H; Li D; Zhang J; Wang M Biomed Pharmacother; 2013 Sep; 67(7):599-606. PubMed ID: 23906761 [TBL] [Abstract][Full Text] [Related]
17. [Prokaryotic expression, purification and identification of recombinant Xenopus laevis and mouse vascular endothelial growth factors]. Niu T; Liu T; Jia YQ; Yang L; Tian L; Liu JY; Hu B; Wu Y; Wei YQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):301-4. PubMed ID: 15931851 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli. Kim S; Mohamedali KA; Cheung LH; Rosenblum MG J Biotechnol; 2007 Feb; 128(3):638-47. PubMed ID: 17218033 [TBL] [Abstract][Full Text] [Related]
19. [Expression of extracellular domain of VEGF receptor KDR with recombinant AAV]. Zeng GF; Zhang LG; Zhang ZQ Sheng Wu Gong Cheng Xue Bao; 2001 Jul; 17(4):388-91. PubMed ID: 11702693 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]